Patients with pollen-related allergic rhinitis prefer on demand antihistamines, with treatment preferences differing markedly ...

In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...

The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies developing candidates such as EBGLYSS ...

The guidelines focus on three key clinical statements. The American College of Allergy, Asthma, and Immunology (ACAAI) has issued updated guidelines on the treatment of seasonal allergic rhinitis (SAR ...

Although biologics can be effective in reducing allergy symptoms, the high cost of these medications must be weighed when determining whether to use them for allergic rhinitis. But these typical ...

The pharmacologic agents most often prescribed for patients with AR include oral H 1-antihistamines, intranasal or intraocular H 1-antihistamines, intranasal corticosteroids, nasal decongestants, ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Among patients with allergic rhinitis (AR), misdiagnosis ...

Recent developments in allergen immunotherapy, improvements in primary care, and the emergence of a new treatment for other allergic conditions have improved the quality of care for seasonal allergies ...

Biopharmaceutical company Allovate has signed an agreement with personalized medicine firm Restore Health for the exclusive rights to provide Allerdent, a new therapeutic toothpaste delivery system ...

DUBLIN--(BUSINESS WIRE)--The "Global Allergic Rhinitis Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering. The research provides insights into ...

The "Allergic Rhinitis Market- A Global and Regional Analysis: Focus on Drug Class and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The global ...

(MENAFN- GlobeNewsWire - Nasdaq) The perennial allergic rhinitis market is projected to progress steadily, supported by a relatively small but focused pipeline of emerging therapies. Companies ...